{"title":"勘误:嵌合抗原受体T细胞治疗非霍奇金淋巴瘤的曙光","authors":"Karlo Perica, M. Lia Palomba, Renier J. Brentjens","doi":"10.1002/acg2.44","DOIUrl":null,"url":null,"abstract":"<p>The above paper<sup>1</sup> was published in Volume 1 Issue 3 of <i>Advances in Cell and Gene Therapy</i>. The authors have identified an error in the Introduction which they would like to amend.</p><p>In the final paragraph of page 1, the first sentence “The most common toxicity of CAR therapy is Cytokine Release….” should read “The most common toxicity of CAR therapy is Cytokine Release Syndrome (CRS),<sup>8,19,20</sup> which manifests on a spectrum from mild fever to severe multi-organ dysfunction requiring intensive care.”</p><p>The authors apologize for the error.</p>","PeriodicalId":72084,"journal":{"name":"Advances in cell and gene therapy","volume":"2 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/acg2.44","citationCount":"0","resultStr":"{\"title\":\"Corrigendum: Dawn of chimeric antigen receptor T cell therapy in non-Hodgkin Lymphoma\",\"authors\":\"Karlo Perica, M. Lia Palomba, Renier J. Brentjens\",\"doi\":\"10.1002/acg2.44\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The above paper<sup>1</sup> was published in Volume 1 Issue 3 of <i>Advances in Cell and Gene Therapy</i>. The authors have identified an error in the Introduction which they would like to amend.</p><p>In the final paragraph of page 1, the first sentence “The most common toxicity of CAR therapy is Cytokine Release….” should read “The most common toxicity of CAR therapy is Cytokine Release Syndrome (CRS),<sup>8,19,20</sup> which manifests on a spectrum from mild fever to severe multi-organ dysfunction requiring intensive care.”</p><p>The authors apologize for the error.</p>\",\"PeriodicalId\":72084,\"journal\":{\"name\":\"Advances in cell and gene therapy\",\"volume\":\"2 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1002/acg2.44\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in cell and gene therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/acg2.44\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in cell and gene therapy","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/acg2.44","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Corrigendum: Dawn of chimeric antigen receptor T cell therapy in non-Hodgkin Lymphoma
The above paper1 was published in Volume 1 Issue 3 of Advances in Cell and Gene Therapy. The authors have identified an error in the Introduction which they would like to amend.
In the final paragraph of page 1, the first sentence “The most common toxicity of CAR therapy is Cytokine Release….” should read “The most common toxicity of CAR therapy is Cytokine Release Syndrome (CRS),8,19,20 which manifests on a spectrum from mild fever to severe multi-organ dysfunction requiring intensive care.”
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
